Commentary
CYP17 and breast cancer: no overall effect, but what about interactions?
-
* Corresponding author: Julian Little jlittle@uottawa.ca
Breast Cancer Research 2005, 7:238-242 doi:10.1186/bcr1320
See related research articles by Verla-Tebit et al (http://breast-cancer-research.com/content/7/4/R455), Chang et al (http://breast-cancer-research.com/content/7/4/R513) and Einarsdottir et al (http://breast-cancer-research.com/content/7/4/R890).
No comments have yet been made on this article.